About
Pattern Bioscience is a pioneering biotechnology company on a mission to tackle the global health crisis of antimicrobial resistance with its culture-free, rapid diagnostic technology. Each year, drug-resistant bacterial infections claim over a million lives worldwide and cost billions in healthcare, yet traditional diagnostics remain slow and outdated. Pattern’s breakthrough system leverages single-cell analysis and machine learning to deliver fast, clinically actionable pathogen identification and antibiotic susceptibility test results in hours instead of days. This innovation empowers physicians to get patients the right treatment faster—saving lives, reducing side effects, and lowering healthcare costs.